Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
AMPH Revenue Growth (YoY Quarterly)•-1.83%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-1.83%
-3.4pp
-1.13%
+2.1pp
-40.75%
-1.7pp
-21.13%
+34.5pp
-35.65%
+21.4pp
-32.05%
+22.2pp
-31.08%
+21.5pp
-5.21%
-0.8pp
-9.40%
-1.3pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +4.73% | -0.76% | -4.38% | +1.60% | -1.83% |
| Gross Profit Growth | -9.87% | -2.34% | -9.12% | -3.23% | -1.13% |
| EBITDA Growth | +0.71% | -15.52% | -15.26% | -39.07% | -40.75% |
| Operating Income Growth | -16.37% | -22.32% | -23.60% | -55.62% | -21.13% |
| Net Income Growth | +4.97% | -41.44% | -18.23% | -57.09% | -35.65% |
| EPS Growth | +4.00% | -41.11% | -15.38% | -54.22% | -32.05% |
| EPS Diluted Growth | +8.82% | -37.04% | -12.33% | -52.56% | -31.08% |
| Weighted Average Shares Growth | +0.98% | -1.18% | -4.00% | -4.42% | -5.21% |
| Weighted Average Shares Diluted Growth | -1.80% | -5.89% | -7.53% | -8.07% | -9.40% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +21.62% | -36.56% | -48.50% | -12.31% | +13.23% |
| Free Cash Flow Growth | +15.19% | -47.57% | -60.32% | +2.31% | +48.02% |
| Receivables Growth | +19.54% | +4.68% | +1.90% | +1.26% | +4.00% |
| Inventory Growth | +45.27% | +60.59% | +56.63% | +42.68% | +15.06% |
| Asset Growth | +4.27% | +3.30% | +8.30% | +7.83% | +3.29% |
| Book Value per Share Growth | +13.41% | +13.08% | +10.62% | +11.67% | +13.63% |
| Debt Growth | +4.31% | +4.05% | +5.63% | +4.27% | +0.84% |
| R&D Expense Growth | -11.15% | +41.19% | +13.75% | +6.06% | +28.51% |
| SG&A Expenses Growth | +7.46% | +11.24% | +8.65% | +114.02% | +14.50% |
1 / 4